- Amgen lays off around 40 employeesFollow along as BioSpace tracks job cuts and restructuring initiatives.BioSpace · 4h ago↗ source
- Anthropic’s life science plans; Novartis CEO on China deals; and moreWelcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are set to report their Q2 results. In the meant…Endpoints · 1d ago↗ source
- Amgen shares new Tavneos analysis in effort to resolve FDA disputeAmgen shared a new analysis with the FDA that the company said supports keeping its controversial rare disease drug Tavneos on the market. The submission, made Thursday, includes an independent r…Endpoints · 2d ago↗ source